136995-25-0

Basic information

• Product Name: 5-Methoxymethyl-isoxazole-4-carboxylic acid (4-trifluoromethyl-phenyl)-amide
• Synonyms: 5-Methoxymethyl-isoxazole-4-carboxylic acid (4-trifluoromethyl-phenyl)-amide
• CAS NO: 136995-25-0
• Molecular Weight: 300.237
• Mol File: 136995-25-0.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 5-Methoxymethyl-isoxazole-4-carboxylic acid (4-trifluoromethyl-phenyl)-amide(CAS DataBase Reference)
• NIST Chemistry Reference: 5-Methoxymethyl-isoxazole-4-carboxylic acid (4-trifluoromethyl-phenyl)-amide(136995-25-0)
• EPA Substance Registry System: 5-Methoxymethyl-isoxazole-4-carboxylic acid (4-trifluoromethyl-phenyl)-amide(136995-25-0)

Safety Data

• Hazardous Substances Data: 136995-25-0(Hazardous Substances Data)

Upstream product

• 127958-23-0 methyl 2-[(dimethylamino)methylene]-4-methoxy-3-oxobutanoate 
• 41051-15-4 4-methoxyacetoacetic acid methylester 
• 134540-99-1 methyl 5-(methoxymethyl)isoxazole-4-carboxylate 
• 134541-08-5 5-(methoxymethyl)isoxazole-4-carboxylic acid 
• 455-14-1 4-trifluoromethylphenylamine 
• 136995-30-7 5-Methoxymethyl-isoxazole-4-carbonyl chloride 

Downstream Products

• 1058722-46-5 C₁₂H₉F₃N₂O₃ 

Relevant articles and documents

COMPOSITIONS AND METHODS FOR THE TREATMENT OF PERIODONTITIS AND RHEUMATOID ARTHRITIS

The invention relates to the compounds of formula I or its pharmaceutical acceptable salts, as well as polymorphs, solvates, enantiomers, stereoisomers and hydrates thereof. The pharmaceutical compositions comprising an effective amount of compounds of formula I, and methods for the treatment of periodontitis and rheumatoid arthritis may be formulated for oral, buccal, rectal, topical, transdermal, transmucosal, intravenous, parenteral administration, syrup, or injection.